Aberrant NEAT1 promotes migration in endometrial cancer and as marker of poor prognosis

被引:0
作者
Shen, Yuan [1 ]
Wang, Xiaoyu [1 ]
Lu, Lin [2 ]
Meng, Wei [3 ]
机构
[1] Jinan Univ, Affiliated Hosp 1, Dept Gynecol & Obstet, 613 Western Huangpu Ave Tianhe Dist, Guangzhou 510630, Guangdong, Peoples R China
[2] Southern Med Univ, Dept Gynecol & Obstet, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China
[3] Southern Med Univ, Inst Genet Engn, 1838 North Guangzhou Ave, Guangzhou 510515, Guangdong, Peoples R China
来源
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY | 2017年 / 10卷 / 03期
关键词
Endometrial cancer; metastasis; long non-coding RNA; NEAT1; LONG NONCODING RNAS; CARCINOMA; METAANALYSIS; INVASION;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
NEAT1 shares homology with NEAT2 (also known as MALAT-1), which is a well characterized lncRNA that promotes the migration of malignant cells. However, the function of NEAT1 in endometrial cancer (EC) remains unknown. Here, we investigated the NEAT1 expression levels in EC tissue using ISH. The median score of NEAT1 in EC tissues was used as a cutoff value to divided the patient cohort into 2 groups, the high expression and low expression groups for further analysis of the correlation between the NEAT1 levels and the clinical characteristics of EC. Moreover, we silenced NEAT1 in EC cells, and measured cell mobility using the wound healing and transwell assays. We found that the level of NEAT1 was a marker of poor prognosis of EC; elevated NEAT1 levels corresponded to a lower OS and were closely related with metastasis. Knocking down NEAT1 in EC cells significantly inhibited cell mobility. Consequently, our findings suggest that NEAT1 promotes migration and may serve as a predictive marker for EC patients.
引用
收藏
页码:3716 / 3721
页数:6
相关论文
共 25 条
  • [1] The role of non-coding RNAs in diabetic nephropathy: Potential applications as biomarkers for disease development and progression
    Alvarez, M. Lucrecia
    DiStefano, Johanna K.
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2013, 99 (01) : 1 - 11
  • [2] Predictive Modeling: A New Paradigm for Managing Endometrial Cancer
    Bendifallah, Sofiane
    Darai, Emile
    Ballester, Marcos
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2016, 23 (03) : 975 - 988
  • [3] Serum HE4 detects recurrent endometrial cancer in patients undergoing routine clinical surveillance
    Brennan, Donal J.
    Hackethal, Andreas
    Mann, Kristy P.
    Mutz-Dehbalaie, Irene
    Fiegl, Heidi
    Marth, Christian
    Obermair, Andreas
    [J]. BMC CANCER, 2015, 15
  • [4] Chen Y, 2016, EUR REV MED PHARMACO, V20, P1974
  • [5] DilleY J, 2016, MINERVA GINECOL, V68, P497
  • [6] Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
    Ferlay, Jacques
    Soerjomataram, Isabelle
    Dikshit, Rajesh
    Eser, Sultan
    Mathers, Colin
    Rebelo, Marise
    Parkin, Donald Maxwell
    Forman, David
    Bray, Freddie
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2015, 136 (05) : E359 - E386
  • [7] Long noncoding RNA NEAT1 is an unfavorable prognostic factor and regulates migration and invasion in gastric cancer
    Fu, Jing-wei
    Kong, Ying
    Sun, Xu
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2016, 142 (07) : 1571 - 1579
  • [8] MicroRNA 140 Promotes Expression of Long Noncoding RNA NEAT1 in Adipogenesis
    Gernapudi, Ramkishore
    Wolfson, Benjamin
    Zhang, Yongshu
    Yao, Yuan
    Yang, Peixin
    Asahara, Hiroshi
    Zhou, Qun
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2016, 36 (01) : 30 - 38
  • [9] Molecular anatomy of a speckle
    Hall, Lisa L.
    Smith, Kelly P.
    Byron, Meg
    Lawrence, Jeanne B.
    [J]. ANATOMICAL RECORD PART A-DISCOVERIES IN MOLECULAR CELLULAR AND EVOLUTIONARY BIOLOGY, 2006, 288A (07): : 664 - 675
  • [10] Aberrant NEAT1 expression is associated with clinical outcome in high grade glioma patients
    He, Chengbiao
    Jiang, Bing
    Ma, Jianrong
    Li, Qiaoyu
    [J]. APMIS, 2016, 124 (03) : 169 - 174